What do systematic reviews say?

13 questions · 13 findings · 3 reviews · Hypertension

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 7.7%Moderate 2 · 15.4%High 10 · 76.9%

Intervention not reported

mg/day LDL cholesterol · participants with normal or abnormal lipid profiles

The intervention showed no clear difference in mg/day LDL cholesterol (high certainty).

1 finding from 1 review

Pravastatin for lowering lipids 2023 · Cochrane Headline outcomes only
no estimate extracted
11 studies · 765 participants
High

Intervention not reported

mg/day LDL cholesterol · participants with normal or abnormal lipid profiles

The intervention showed no clear difference in mg/day LDL cholesterol (moderate certainty).

1 finding from 1 review

Pravastatin for lowering lipids 2023 · Cochrane Headline outcomes only
no estimate extracted
22 studies · 3117 participants
Moderate

Intervention not reported

mg/day LDL cholesterol · participants with normal or abnormal lipid profiles

The intervention showed no clear difference in mg/day LDL cholesterol (moderate certainty).

1 finding from 1 review

Pravastatin for lowering lipids 2023 · Cochrane Headline outcomes only
no estimate extracted
35 studies · 4869 participants
Moderate

Intervention not reported

mg/day LDL cholesterol · participants with normal or abnormal lipid profiles

The intervention showed no clear difference in mg/day LDL cholesterol (high certainty).

1 finding from 1 review

Pravastatin for lowering lipids 2023 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 881 participants
High

Intervention not reported

LDL‐cholesterol fluvastatin 10 mg/day · participants with normal or abnormal lipid profiles

1 finding from 1 review

Fluvastatin for lowering lipids 2018 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 595 participants
High

Intervention not reported

LDL‐cholesterol fluvastatin 20 mg/day · participants with normal or abnormal lipid profiles

1 finding from 1 review

Fluvastatin for lowering lipids 2018 · Cochrane Headline outcomes only
no estimate extracted
55 studies · 9010 participants
High

Intervention not reported

LDL‐cholesterol fluvastatin 40 mg/day · participants with normal or abnormal lipid profiles

1 finding from 1 review

Fluvastatin for lowering lipids 2018 · Cochrane Headline outcomes only
no estimate extracted
57 studies · 3658 participants
High

Intervention not reported

LDL‐cholesterol fluvastatin 80 mg/day · participants with normal or abnormal lipid profiles

1 finding from 1 review

Fluvastatin for lowering lipids 2018 · Cochrane Headline outcomes only
no estimate extracted
32 studies · 4928 participants
High

Intervention not reported

LDL‐Cholesterol rosuvastatin 5 mg/day · participantswith normal or abnormal lipid profiles

1 finding from 1 review

Rosuvastatin for lowering lipids 2014 · Cochrane Headline outcomes only
no estimate extracted
25 studies · 2602 participants
High

Intervention not reported

LDL‐Cholesterol rosuvastatin 10 mg/day · participantswith normal or abnormal lipid profiles

1 finding from 1 review

Rosuvastatin for lowering lipids 2014 · Cochrane Headline outcomes only
no estimate extracted
74 studies · 9855 participants
High

Intervention not reported

LDL‐Cholesterol rosuvastatin 20 mg/day · participantswith normal or abnormal lipid profiles

1 finding from 1 review

Rosuvastatin for lowering lipids 2014 · Cochrane Headline outcomes only
no estimate extracted
28 studies · 3675 participants
High

Intervention not reported

LDL‐Cholesterol rosuvastatin 40 mg/day · participantswith normal or abnormal lipid profiles

1 finding from 1 review

Rosuvastatin for lowering lipids 2014 · Cochrane Headline outcomes only
no estimate extracted
18 studies · 3512 participants
High

Intervention not reported

LDL‐Cholesterol rosuvastatin 2.5 mg/day · participantswith normal or abnormal lipid profiles

1 finding from 1 review

Rosuvastatin for lowering lipids 2014 · Cochrane Headline outcomes only
no estimate extracted
11 studies · 450 participants
Low